| Dr Robert J Weissman, AUD | |
|
50 Alessandro Pl, Suite 230, Pasadena, CA 91105-3149 | |
| (626) 796-9510 | |
| (626) 796-9520 |
| Full Name | Dr Robert J Weissman |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 50 Alessandro Pl, Pasadena, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841293305 | NPI | - | NPPES |
| AU0020600 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AU2060 (California) | Primary |
| Provider Name | Ent Surgical Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336126820 PECOS PAC ID: 6103897988 Enrollment ID: O20040804001209 |
News Archive
Nearly 80 percent of women feel the new guidelines against breast cancer are unsafe as they stated that screening for those under 50 is not mandatory. The controversy over screening mammography flared up in late 2009, when a government-funded group of independent experts decided to change its recommendations. Instead of advising annual mammograms in all women age 40 and above, the U.S. Preventive Services Task Force (USPSTF) said women shouldn't routinely get screened until they hit 50, and those between 50 and 74 should only have mammograms every two years. But most of the women also seriously overestimate their risk of developing the disease, researchers from the University of Massachusetts Medical School in Worcester found.
Meanwhile, Congress flirted with disaster as it appeared unlikely to meet deadlines to approve a series of budget bills, including an extension of the federal government's lending authority. But lawmakers found ways to extend programs long enough to continue negotiating through the fall.
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
What's new: Researchers at MIT and San Camillo Hospital in Venice, Italy, have shown that motor impairments in stroke patients can be understood as impairments in specific combinations of muscle activity, known as synergies.
Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.
› Verified 9 days ago
| Provider Name | Robert-jayson Communications |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205839768 PECOS PAC ID: 8921073362 Enrollment ID: O20040830000818 |
News Archive
Nearly 80 percent of women feel the new guidelines against breast cancer are unsafe as they stated that screening for those under 50 is not mandatory. The controversy over screening mammography flared up in late 2009, when a government-funded group of independent experts decided to change its recommendations. Instead of advising annual mammograms in all women age 40 and above, the U.S. Preventive Services Task Force (USPSTF) said women shouldn't routinely get screened until they hit 50, and those between 50 and 74 should only have mammograms every two years. But most of the women also seriously overestimate their risk of developing the disease, researchers from the University of Massachusetts Medical School in Worcester found.
Meanwhile, Congress flirted with disaster as it appeared unlikely to meet deadlines to approve a series of budget bills, including an extension of the federal government's lending authority. But lawmakers found ways to extend programs long enough to continue negotiating through the fall.
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
What's new: Researchers at MIT and San Camillo Hospital in Venice, Italy, have shown that motor impairments in stroke patients can be understood as impairments in specific combinations of muscle activity, known as synergies.
Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.
› Verified 9 days ago
| Provider Name | Drhear Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851917819 PECOS PAC ID: 5496113078 Enrollment ID: O20230614003230 |
News Archive
Nearly 80 percent of women feel the new guidelines against breast cancer are unsafe as they stated that screening for those under 50 is not mandatory. The controversy over screening mammography flared up in late 2009, when a government-funded group of independent experts decided to change its recommendations. Instead of advising annual mammograms in all women age 40 and above, the U.S. Preventive Services Task Force (USPSTF) said women shouldn't routinely get screened until they hit 50, and those between 50 and 74 should only have mammograms every two years. But most of the women also seriously overestimate their risk of developing the disease, researchers from the University of Massachusetts Medical School in Worcester found.
Meanwhile, Congress flirted with disaster as it appeared unlikely to meet deadlines to approve a series of budget bills, including an extension of the federal government's lending authority. But lawmakers found ways to extend programs long enough to continue negotiating through the fall.
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
What's new: Researchers at MIT and San Camillo Hospital in Venice, Italy, have shown that motor impairments in stroke patients can be understood as impairments in specific combinations of muscle activity, known as synergies.
Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert J Weissman, AUD Po Box 50735, Pasadena, CA 91115-0735 Ph: (626) 796-9510 | Dr Robert J Weissman, AUD 50 Alessandro Pl, Suite 230, Pasadena, CA 91105-3149 Ph: (626) 796-9510 |
News Archive
Nearly 80 percent of women feel the new guidelines against breast cancer are unsafe as they stated that screening for those under 50 is not mandatory. The controversy over screening mammography flared up in late 2009, when a government-funded group of independent experts decided to change its recommendations. Instead of advising annual mammograms in all women age 40 and above, the U.S. Preventive Services Task Force (USPSTF) said women shouldn't routinely get screened until they hit 50, and those between 50 and 74 should only have mammograms every two years. But most of the women also seriously overestimate their risk of developing the disease, researchers from the University of Massachusetts Medical School in Worcester found.
Meanwhile, Congress flirted with disaster as it appeared unlikely to meet deadlines to approve a series of budget bills, including an extension of the federal government's lending authority. But lawmakers found ways to extend programs long enough to continue negotiating through the fall.
Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.
What's new: Researchers at MIT and San Camillo Hospital in Venice, Italy, have shown that motor impairments in stroke patients can be understood as impairments in specific combinations of muscle activity, known as synergies.
Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.
› Verified 9 days ago
Yoshio J Furuya Maccca Aud Corp Audiologist Medicare: Not Enrolled in Medicare Practice Location: 960 E Green St, Suite 101, Pasadena, CA 91106 Phone: 626-795-0679 Fax: 626-795-5822 | |
Dr. Allison Granali, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 301 E Del Mar Blvd, Pasadena, CA 91101 Phone: 626-796-2016 | |
Western Audiology Audiologist Medicare: Medicare Enrolled Practice Location: 50 Alessandro Pl, Suite 230, Pasadena, CA 91105 Phone: 626-796-9510 Fax: 626-796-9520 | |
Hear Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 301 E Del Mar Blvd, Pasadena, CA 91101 Phone: 626-796-2016 Fax: 626-796-2320 | |
Rebecca Arroyo, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 301 E Del Mar Blvd, Pasadena, CA 91101 Phone: 626-796-2016 | |
Yoshio Jimmy Furuya, MA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 960 E Green St, Suite 101, Pasadena, CA 91106 Phone: 626-795-0679 Fax: 626-795-5822 | |
Ellen Simon, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 301 E Del Mar Blvd, Pasadena, CA 91101 Phone: 626-796-2014 Fax: 626-796-2320 |